𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Point mutations can inactivate in vitro and in vivo activities of p16INK4a/CDKN2A in human glioma

✍ Scribed by Arap, Wadih; Knudsen, Erik S; Wang, Jean YJ; Cavenee, Webster K; Huang, H-J Su

Book ID
110060522
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
440 KB
Volume
14
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predicting functional significance of ca
Predicting functional significance of cancer-associated p16INK4a mutations in CDKN2A
✍ Heather A. McKenzie; Carina Fung; Therese M. Becker; Mal Irvine; Graham J. Mann; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 350 KB πŸ‘ 1 views

Inherited mutations affecting the INK4a/ARF locus (CDKN2A) are associated with melanoma susceptibility in 40% of multiple case melanoma families. Over 60 different germline INK4a/ARF mutations have been detected in more than 190 families worldwide. The majority of these alterations are missense muta

No p16INK4A/CDKN2/MTS1 mutations indepen
No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas
✍ Meye, Axel; WΓΌrl, Peter; Hinze, Raoul; Berger, Dieter; Bache, Matthias; Schmidt, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

The p16 INK4A /CDKN2/MTS1 gene encodes a specific inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. This study investigates p16 INK4A gene status and expression in mesenchymal tumours, in particular soft tissue sarcomas (STSs). Employing non-radioactive polymerase chain reaction-single strand co

In vitro and in vivo tumor growth inhibi
In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells
✍ Douglas M. Noonan; Anna Severino; Monica Morini; Alessandra Tritarelli; Lucrezia πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 255 KB

## Abstract The cell cycle regulatory pathway responsible for the control of the late‐G1 checkpoint is found recurrently altered in human malignant melanoma, often due to lack of functional p16 or pRb (pRb‐1) proteins. Here we examined the ability of p16‐derived peptides to mimic p16 function in tw